Healing and Dealing

Rumours that the special relationship may be at an end are clearly premature, as His Majesty's Government has happily joined the Trumpster and his head-tribble in yet another assault on Britain's enemies in the public sector. The despised National Health Service, which all three major parties and the Conservatives have been diligently kicking for the past four decades, is likely to pay the price for a drug deal whose terms are so favourable that Team Starmer has kept them secret until the crucifixion and resurrection of the Saviour and the climax of the national chocolate egg crisis were available to provide a distraction. Some of the Trumpster's tariffs on British exports will be skirted, at least until the head-tribble's whims decree otherwise; but the costs are still estimated substantially to exceed any savings for the mainland. Presumably His Majesty's Government intends making up the shortfall with money saved on resident doctors; although it remains as yet unclear how far such savings will run into the necessary thousands of millions. Fortunately, the deal has the approval of drug company bosses and the ministers they pay for, so no doubt all will turn out well where it matters.